GlaxoSmithKline Consumer Healthcare voluntarily recalled all alli weight loss products from United States and Puerto Rico retailers because the company believes some packages were tampered with and may contain product not authentic.
The company is conducting an investigation and is working with the knowledge of the U.S. Food and Drug Administration on this retailer level recall.
The investigation was triggered by calls by consumers in seven states to GlaxoSmithKline that bottles of alli purchased in retail stores contained tablets and capsules that were not alli.
A range of tablets and capsules of various shapes and colors were reported to be found inside bottles, while some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic.
“Safety is our first priority and we are asking retailers and pharmacies to remove all alli from their shelves immediately,” Colin Mackenzie, president consumer Healthcare North America, said in a statement. “We have posted a consumer alert on our website, www.myalli.com, and issued a news release with information and photographs to help consumers determine if their alli is authentic.”
The product is a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat" and is packaged in a labeled bottle that has an inner foil seal imprinted with the words: “Sealed for Your Protection.”
Consumers should confirm any alli in their possession matches this description. Pictures of the product are available on the website: www.myalli.com.
Those who have this product they are unsure or concerned about should not use it and call GlaxoSmithKline at 1-800-671-2554. Those who have consumed questionable product should also contact their healthcare providers, Mackenzie said.